Price T Rowe Associates Inc Editas Medicine, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 64,818 shares of EDIT stock, worth $89,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,818

Previous 52,455 23.57%

Holding current value

$89,448

Previous $245,000 9.39%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $41,910 - $73,683	12,363 Added 23.57%	64,818 $222,000
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $12,847 - $20,027	2,751 Added 5.53%	52,455 $245,000
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $50,433 - $79,416	7,174 Added 16.87%	49,704 $369,000
Q4 2023 Feb 14, 2024	SELL	$6.25 - $11.11 $7,887 - $14,020	-1,262 Reduced 2.88%	42,530 $431,000
Q3 2023 Nov 14, 2023	BUY	$6.92 - $9.31 $56,045 - $75,401	8,099 Added 22.69%	43,792 $342,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $3,726 - $6,721	586 Added 1.67%	35,693 $294,000
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $34,306 - $56,266	4,880 Added 16.14%	35,107 $255,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $36,449 - $57,873	-4,381 Reduced 12.66%	30,227 $268,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $46,791 - $74,728	3,848 Added 12.51%	34,608 $424,000
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $57,522 - $122,933	5,758 Added 23.03%	30,760 $364,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $20,120 - $39,483	1,429 Added 6.06%	25,002 $476,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $514,937 - $786,855	-19,395 Reduced 45.14%	23,573 $626,000
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $169,803 - $315,392	4,324 Added 11.19%	42,968 $1.77 Million
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $209,111 - $378,525	6,683 Added 20.91%	38,644 $2.19 Million
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $199,463 - $454,983	5,023 Added 18.65%	31,961 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $729,211 - $2.27 Million	26,938 New	26,938 $1.89 Million

Others Institutions Holding EDIT

# of Institutions

250

Shares Held

56.9M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $94.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Editas Medicine, Inc. Transaction History